1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,189 | 0,238 | 09:29 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.04. | LIFETECH SCI (01302): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 18.04. | LIFETECH SCI (01302): PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON MONDAY, 27 MAY 2024 OR ANY ADJOURNMENT THEREOF | 1 | HKEx | ||
| 18.04. | LIFETECH SCI (01302): (1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES (2) RE-ELECTION OF DIRECTORS AND CONTINUOUS APPOINTMENT OF INDEPENDENT NON-EXECUTIVE ... | 1 | HKEx | ||
| 18.04. | LIFETECH SCI (01302): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023 | - | HKEx | ||
| 18.04. | LIFETECH SCI (01302): ANNUAL REPORT 2023 | - | HKEx | ||
| 16.04. | LIFETECH SCI (01302): PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY | - | HKEx | ||
| 10.04. | LIFETECH SCI (01302): CONNECTED TRANSACTION - SHARE PURCHASE PURSUANT TO SHARE AWARD SCHEME | - | HKEx | ||
| 02.04. | LifeTech Scientific Corporation Announced 2023 Annual Results: International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development | 42 | PR Newswire | SHENZHEN, China, April 2, 2024 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "Lifetech", Stock code: 1302.HK), a company specializing in minimally invasive interventional medical... ► Artikel lesen | |
| 02.04. | LIFETECH SCI (01302): DISCLOSEABLE TRANSACTION - SUBSCRIPTION OF PRINCIPAL-PROTECTED STRUCTURED DEPOSIT | 1 | HKEx | ||
| 28.03. | LIFETECH SCI (01302): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023 | 1 | HKEx | ||
| 08.03. | LIFETECH SCI (01302): PROFIT WARNING | - | HKEx | ||
| 06.03. | LIFETECH SCI (01302): NOTICE OF BOARD MEETING | 1 | HKEx | ||
| 24.01. | LIFETECH SCI (01302): GRANT OF SHARE OPTIONS | 1 | HKEx | ||
| 08.11.23 | LIFETECH SCI (01302): VOLUNTARY ANNOUNCEMENT - PERIPHERAL THROMBUS ASPIRATION CATHETER SYSTEM OBTAINED OFFICIAL REGISTRATION APPROVAL BY THE CHINA NMPA | 2 | HKEx | ||
| 30.08.23 | LifeTech Scientific Corporation (1302.HK) Announces 2023 Interim Results | 218 | PR Newswire | SHENZHEN, China, Aug. 30, 2023 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "Lifetech"), a leading company specialized in minimally invasive interventional medical devices... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 60,61 | +14,40 % | Earnings call: PROCEPT BioRobotics sees 83% revenue surge in Q1 2024 | ||
| ATRICURE | 24,810 | +2,86 % | AtriCure Inc reports results for the quarter ended in March - Earnings Summary | ||
| GENEDX | 20,880 | +22,32 % | Pre-market Movers: Cyclacel Pharmaceuticals, Marin Software, GeneDx, Sensata Technologies, Lichen China | INDIANAPOLIS (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.05 A.M. ET).In the Green Cyclacel Pharmaceuticals, Inc. (CYCC) is up... ► Artikel lesen | |
| ADAPTHEALTH | 10,060 | +2,13 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| RXSIGHT | 56,73 | +8,82 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| MIMEDX | 7,300 | +18,51 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen | |
| FRESENIUS | 28,120 | +0,54 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Fresenius vor Quartalszahlen von 41 auf 40 Euro gesenkt und die Einstufung auf "Buy" belassen. Ein zunächst vorsichtiger... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 18,000 | -2,17 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,340 | +1,87 % | JEFFERIES stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für FMC vor Quartalszahlen von 29 auf 32 Euro angehoben und die Einstufung auf "Underperform" belassen. Nachdem sich der Dialysespezialist... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 51,82 | -0,54 % | Siemens Healthineers: Aktie klettert im DAX - das beflügelt | Die Aktie von Siemens Healthineers sichert sich am Montag einen der Spitzenränge im DAX. Auftrieb verleihen positive News vom Konkurrenten Philips. Dessen Aktie zieht mittlerweile mit einem Plus von... ► Artikel lesen | |
| DOCGO | 3,390 | +0,30 % | Evaluating DocGo: Insights From 8 Financial Analysts | ||
| CASTLE BIOSCIENCES | 22,060 | +4,60 % | Castle Biosciences Inc.: Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx-Melanoma and DecisionDx-SCC Tests on the Management of Patients with Skin Cancer | If choosing to use a molecular test to rule-out a sentinel lymph node biopsy (SLNB) in patients diagnosed with melanoma, it is important to show that patients foregoing an SLNB have low risk outcomes... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,440 | +4,21 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2023 Results | SCOTTSDALE, Ariz., Feb. 28, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 5,220 | +1,36 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2023 Results; Provides Full-Year 2024 Financial Guidance | Reports $1.82 billion in total revenue for full-year 2023 and 119,200 health plan members at year end, up 27.2% and 21.1% year-over-year respectivelyRecords strong health plan membership growth after... ► Artikel lesen |
LIFETECH SCIENTIFIC CORPORATION gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +5,56 % bei einem Aktienkurs von 0,171 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
